Sign in

CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company

Stoke Therapeutics, Inc.

Sign in to watch
Ticker
STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471144582
Phone
781-430-8200
Business address
45 WIGGINS AVENUE, BEDFORD, MA, 01730
Former names
ASOthera Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,050,832
in 7 filings, $404K under 10b5-1 plans

Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 79 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-15 Tulipano Stephen J CFO Grant or award · Restricted Stock Unit (RSU) +52,400 52,400
2023-03-15 Ticho Barry Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +78,600 78,600
2023-03-15 Ticho Barry Chief Medical Officer Grant or award · Restricted Stock Unite (RSU) +52,400 52,400
2023-03-15 Nash Huw M. COO & CBO Grant or award · Employee Stock Option (Right to Buy) +78,600 78,600
2023-03-15 Nash Huw M. COO & CBO Grant or award · Restricted Stock Unit (RSU) +52,400 52,400
2023-03-15 Kaye Edward M. MD CEO Grant or award · Employee Stock Option (Right to Buy) +213,000 213,000
2023-03-15 Kaye Edward M. MD CEO Grant or award · Restricted Stock Unit (RSU) +142,000 142,000
2023-02-06 Ticho Barry Chief Medical Officer Sale −9,235 $10.02 $92K 111,725
2023-02-03 Ticho Barry Chief Medical Officer Sale −3,763 $10.03 $38K 120,960
2023-02-02 Ticho Barry Chief Medical Officer Sale −267 $10.00 $3K 124,723
2023-02-01 Ticho Barry Chief Medical Officer Sale −5,705 $10.02 $57K 124,990
2023-01-31 Ticho Barry Chief Medical Officer Sale −200 $10.00 $2K 130,695
2022-12-07 Tulipano Stephen J CFO Grant or award · Employee Stock Option (Right to Buy) +62,000 62,000
2022-12-07 Ticho Barry Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +62,000 62,000
2022-12-07 Nash Huw M. COO & CBO Grant or award · Employee Stock Option (Right to Buy) +62,000 62,000
2022-12-07 Kaye Edward M. MD CEO Grant or award · Employee Stock Option (Right to Buy) +167,050 167,050
2022-06-07 LEVIN ARTHUR A Director Grant or award · Director Stock Option (Right to Buy) +21,000 21,000
2022-06-07 Menzel Garry E Director Grant or award · Director Stock Option (Right to Buy) +21,000 21,000
2022-06-07 Burstein Jennifer Director Grant or award · Director Stock Option (Right to Buy) +21,000 21,000
2022-06-07 Harrison Seth Loring Director Grant or award · Director Stock Option (Right to Buy) +21,000 21,000

Page 21 of 24 · 461 trades